Coenzyme Q10

Medical Letter on Drugs and Therapeutics

Volumn 48, Issue 1229, 2006, Pages 19-20

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CREATININE; DOXORUBICIN; PLACEBO; UBIDECARENONE; UREA; WARFARIN; ANTIOXIDANT; DRUG DERIVATIVE; UBIQUINONE;

AMYOTROPHIC LATERAL SCLEROSIS; CARDIOMYOPATHY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BIOAVAILABILITY; DRUG COST; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG PURITY; ELECTRON TRANSPORT; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HEART FUNCTION; HUMAN; HUNTINGTON CHOREA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAXIMUM PLASMA CONCENTRATION; MIGRAINE; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; PHOTOAGING; SHORT SURVEY; SUBSTANCE ABUSE; SUPPLEMENTATION; UREA BLOOD LEVEL; URINE VOLUME; CONGESTIVE HEART FAILURE; COST; ECONOMICS; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANTS; CLINICAL TRIALS; COSTS AND COST ANALYSIS; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MIGRAINE DISORDERS; MITOCHONDRIAL ENCEPHALOMYOPATHIES; PARKINSON DISEASE; UBIQUINONE;

EID: 33645455555     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (22)

1. RA Bonakdar and E Guarneri. Coenzyme Q10. Am Fam Physician 2005;72:1065.
2. L Ernster and G Dallner. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995; 1271:195.
3. R Horvath et al. Coenzyme Q10 deficiency and isolated myopathy. Neurology 2006; 66:253.
4. CW Shults et al. Effects of coenzyme Q10 in early Parkinson's disease: evidence of slowing of the functional decline. Arch Neurol 2002; 59:1541.
5. KL Ferrante et al. Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Neurology 2005; 65:1834.
6. Huntington Study Group. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology 2001; 57:397.
7. PS Sandor et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005; 64:713.
8. KA Weant and KM Smith. The role of coenzyme Q10 in heart failure. Ann Pharmacother 2005; 39:1522.
9. M Berman et al. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study. Clin Cardiol 2004; 27:295.
10. J Soongswang et al. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children. Pediatric Cardiol 2005; 26:361.
11. F Rosenfeldt et al. Systematic review of effect of coenzyme Q10 in physicial exercise, hypertension, and heart failure. BioFactors 2003; 18:91.
12. JE Henriksen et al. Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus. Diabet Med 1999; 16:312.
13. JM Hodgson et al. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr 2002; 56:1137.
14. KA Conklin. Coenzyme Q10 for prevention of anthracycline-induced cardiotoxicity. Intergr Cancer Ther 2005; 4:110.
15. C Lamperti et al. Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol 2005; 62:1709.
16. RB Singh et al. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in patients with end-stage renal failure. J Nutr Environ Med 2003; 13:13.
17. MS Reid et al. A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence. Addiction 2005;100 Suppl 1:43.
18. U Hoppe et al. Coenzyme Q10, a cutaneous antioxidant and energizer. BioFactors 1999; 9:371.
19. GN Scott and GW Elmer. Update on natural product-drug interactions. Am J Health Syst Pharm 2002; 59:339.
20. J Engelsen et al. Effect of coenzyme Q10 and gingko biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial. Thromb Haemost 2002; 87:1075.
21. RK Chopra et al. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int J Vitam Nutr Res 1998; 68:109.
22. U Ullmann et al. A new coenzyme Q10 tablet-grade formulation (all-Q) is bioequivalent to Q-Gel and both have better bioavailability properties than Q-SorB. J Med Food 2005; 8:397.